Breast Cancer Detection Market Size, Share, Trends, Growth & Forecast 2034

Breast Cancer Detection Industry Perspective:

The global breast cancer detection market size was worth around USD 5.52 billion in 2024 and is predicted to grow to around USD 11.38 billion by 2034, with a compound annual growth rate (CAGR) of roughly 7.50% between 2025 and 2034.

Request Free Sample

Key Insights:

• As per the analysis shared by our research analyst, the global breast cancer detection market is estimated to grow annually at a CAGR of around 7.50% over the forecast period (2025-2034)
• In terms of revenue, the global breast cancer detection market size was valued at around USD 5.52 billion in 2024 and is projected to reach USD 11.38 billion by 2034.
• The breast cancer detection market is projected to grow at a significant rate due to the growing prevalence of breast cancer worldwide.
• Based on the diagnosis type, the imaging segment is growing at a high rate and will continue to dominate the global market as per industry projections.
• Based on the end-user, the hospitals & clinics segment is anticipated to command the largest market share.
• Based on region, North America is projected to dominate the global market during the forecast period.

Breast Cancer Detection Market: Overview

Breast cancer detection refers to tools and methods used for the diagnosis of breast cancer, either in earlier stages or after the symptoms appear. Detection of breast cancer is carried out using several methods such as biopsies, ultrasound, mammograms, and magnetic resonance imaging (MRI). According to healthcare experts, early detection of breast cancer is essential for ensuring improved treatment results. Breast cancer is a commonly occurring cancer type in women. It is caused by the presence of cancerous or malignant cells in breast tissue. Cancer cells and tissues originating in the breast can spread to other parts if they remain untreated or undiagnosed for an extended period. Breast cancer is of different types, but the two most common variants are invasive lobular carcinoma and invasive ductal carcinoma.

During the forecast period, demand for effective breast cancer detection technologies is expected to continue growing with the rising prevalence of the medical condition across the globe. In addition to this, surging awareness about breast cancer and the importance of early detection will further help the industry thrive.

During the forecast period, increasing investments in the development of novel breast cancer detection methods and solutions will encourage improved revenue. A major drawback for the industry is the lack of effective cancer healthcare infrastructure in emerging parts of the world.

Breast Cancer Detection Market: Growth Drivers

Growing prevalence of breast cancer worldwide is expected to influence the market demand rate

The global breast cancer detection market is expected to be driven by the rising prevalence of breast cancer across the globe. According to the American Cancer Society, breast cancer is the most common type of cancer in the US, apart from skin cancer. It affects nearly 1 in every 3 women. The agency also estimates that the breast cancer incidence rate has increased by 1% in the US in the last few years. There are different types of breast cancer, including lobular breast cancer and ductal carcinoma in situ (DCIS), which are more common.

The less common types of breast cancer are Paget’s disease of the breast, inflammatory breast cancer (IBC), and triple-negative breast cancer (TNBC). Common symptoms of breast cancer include the formation of a lump near the breast region, a change in contour, shape, or size of the breast, a hardened area under the skin appearing like a marble, and clear or blood-stained fluid discharge from the breast. The Cleveland Clinic estimates a number of reasons for breast cancer. The most common risk factors are family history, genetics, older age, alcohol consumption, smoking, and undergoing hormone replacement therapy (HRT). As breast cancer becomes a global health concern, demand for cancer detection is expected to grow simultaneously.

Will rising awareness about breast cancer worldwide influence the breast cancer detection market expansion in the long run?

Public awareness about breast cancer has improved in the last few years. General perception concerning breast cancer, its diagnosis, and treatment has been influenced by several factors. For instance, a rising number of awareness initiatives by governments and healthcare companies has been pivotal to heightened knowledge among the general public.

For instance, in June 2025, Akhila Malayalee Mahila Association and the women’s wing of Madras Kerala Samaj held a breast cancer awareness drive in India’s Chennai city. The program was held in association with the Saaisha India Association and included a one-day workshop to manufacture handmade breast prostheses using mercerized cotton yarns. The global breast cancer detection market is expected to benefit from the surging number of awareness initiatives undertaken by private and public organizations worldwide.

Breast Cancer Detection Market: Restraints

Does the high cost of diagnosis and growing cases of incorrect detection affect the breast cancer detection market revenue?

The global breast cancer detection industry is expected to be restricted due to the high cost of diagnosis. According to industry research, the average cost of breast cancer diagnosis is more than USD 35,000 in the US. The cost of treatment increases further. In developing countries, financial factors remain a major barrier to breast cancer detection.

Additionally, the growing number of incorrect diagnoses has further weakened the industry growth trends in the last few years. Breast cancer does not manifest in symptoms in a large number of cases, which can lead to a missed diagnosis.

Breast Cancer Detection Market: Opportunities

How does rising introduction of new tools and methods open novel growth opportunities for breast cancer detection industry?

The global breast cancer detection market is expected to generate growth opportunities due to growing technological advancements in the field. Industry players are increasingly working on developing more effective breast cancer detection systems with a special focus on early diagnosis. In July 2025, KEM Hospital in India’s Mumbai city, announced the launch of the facility’s most expensive Brihanmumbai Municipal Corporation (BMC)-funded clinical trial.

The study will be conducted over 12 to 28 months and involve around 7000 women, aiming to change the way breast cancer is diagnosed. KEM hospital will use a thermal imaging technology powered by Artificial Intelligence (AI). In May 2025, Kromek launched a new machine prototype for detecting tumors in women with dense breast tissue. The innovation is launched in collaboration with University College London, Newcastle University, and Newcastle Hospitals.

Additionally, the project has been funded by Innovate UK, which provided a fund of £2.5m. The prototype is expected to enter clinical trials upon completion of prototype testing. Furthermore, growing advancements in technologies concerning multi-cancer early detection (MCED) will fuel higher growth in the industry during the forecast period.

Breast Cancer Detection Market: Challenges

Lack of effective infrastructure and awareness in emerging economies impacts market expansion

The global breast cancer detection industry is expected to be challenged by the lack of effective infrastructure supporting early diagnosis of breast cancer, especially when dealing with larger population groups. Furthermore, limited awareness about different aspects of breast cancer in developing economies or remote areas across the globe will further affect market growth trends during the forecast period. Other factors, such as regulatory hurdles and risk of technological obsolescence, may affect the market growth rate in the future.

Breast Cancer Detection Market: Report Scope

Breast Cancer Detection Market: Segmentation

The global breast cancer detection market is segmented based on diagnosis type, application, end-user, and region.

Based on the diagnosis type, the global market segments are blood tests, genomic tests, biopsy, imaging, and others. In 2024, more than 50% of the total revenue was listed in the imaging segment, as it is the most common type of diagnostic technology used worldwide. Higher segmental preference is due to the cost-effectiveness of imaging solutions. Additionally, it is a non-invasive medical procedure and widely considered the most recommended diagnostic method in the initial stages of cancer detection.

Based on application, the global breast cancer detection industry is divided into prognostic, diagnostic & predictive, screening, and others.

Based on the end-user, the global market divisions are diagnostic centers & medical laboratories, hospitals & clinics, and others. In 2024, around 52% of the final results were registered in the hospitals & clinics segment. The rising expansion of healthcare facilities, including cancer treatment offering hospitals, is expected to fuel segmental expansion in the coming years. Diagnostic centers & medical laboratories may account for the second-highest revenue-generating segment in the coming years.

Breast Cancer Detection Market: Regional Analysis

What factors assist North America in taking the lead in the breast cancer detection market?

The global breast cancer detection market is expected to be led by North America during the projection period. Regional countries such as Canada and the US have thriving healthcare ecosystems. The regional market growth rate is influenced by early and rapid adoption of advanced medical technologies, including imaging systems and other diagnostic tools.

In May 2025, the US Food & Drug Administration (FDA) announced the approval of the first AI tool equipped to predict five-year breast cancer risk using results from regular mammograms. The product, developed by US-based Clarity Breast, may help the regional industry thrive during the forecast period.

Asia-Pacific will emerge as the second-highest revenue-generating region in the breast cancer detection industry. The growing prevalence of breast cancer among the regional population will fuel the expansion of the Asian market. Moreover, increasing regional investment in cancer research and expansion of cancer treatment facilities will be crucial to the region’s final revenue.

Furthermore, rising awareness about the importance of early detection of breast cancer may instill higher demand in the region for associated cancer detection technologies. In May 2025, Siemens Healthineers announced the launch of MAMMOMAT B.brilliant in the Indonesian market. The tool is expected to help the region advance early breast cancer diagnosis.

Breast Cancer Detection Market: Competitive Analysis

The global breast cancer detection market is led by players like:

• Canon Medical Systems
• GE Healthcare
• Philips Healthcare
• ScreenPoint Medical
• iBreastExam (UE LifeSciences)
• Natera Inc.
• Siemens Healthineers
• Niramai Health Analytix
• Roche Diagnostics
• Hologic Inc.
• iSono Health
• Guardant Health
• Fujifilm Holdings Corporation
• Braster S.A.
• iCAD Inc.

The global breast cancer detection market is segmented as follows:

By Diagnosis Type

• Blood Tests
• Genomic Tests
• Biopsy
• Imaging
• Others

By Application

• Prognostic
• Diagnostic & Predictive
• Screening
• Others

By End-User

• Diagnostic Centers & Medical Laboratories
• Hospitals & Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa